Balives, Rosalinda B.
HRN: 27-08-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2025
CEFTRIAXONE 1G (VIAL)
05/06/2025
05/13/2025
IVTT
2g
OD
Open Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes